Leveraging Innovation Intelligence - Deep Tech Panel Discussion
CRISPR: Rewriting The Human Genome
Description
Join us for an on-demand, deep tech panel discussion about the future of CRISPR technology. In this series, we dissect our latest CRISPR report and discuss how the market is developing. From personalized medicine to patent pools, partnership trends, and beyond, take a journey into this seemingly endless technology with us. Featuring Frazer Kearl and Piya Jain, the researchers and authors of the report, and Kavya Kumaresan, the Director of Content Operations at PatSnap. Once you complete these on-demand modules, you will have a firm understanding of how the CRISPR technology is evolving, trends shaping its future, and how an analysis like this can be applied to any industry.
Duration
Unit Progress
Modules
Modules
Module 1
Overview of the Report
Duration: 0 Minutes
Kavya, Frazer and Piya discuss the key considerations, research, and the benefits of the report, including what CRISPR technology is and the datasets that stood out as they conducted research.
| Additional Resources |
|---|
| Access the Full Report Now |
Module 2
Case Study
Duration: 0 Minutes
In this section, the panel discusses treatment options different organizations are exploring, especially related to blood disorders. From market size to geographical location, scales of economy, and commercial viability of new treatments, our team explores various possibilities.
| Additional Resources |
|---|
| Access the Full Report Now |
Module 3
Network Analysis
Duration: 0 Minutes
What is the ratio of academic centers competing against one another or working with commercial entities to explore and file patents related to CRISPR technology? In this section, the panel explores this question in detail. From the implications patenting activity has on company strategy to the importance of the relationship between bodies and the network analysis within the report.
| Additional Resources |
|---|
| Access the Full Report Now |
Module 4
Leveraging Patents
Duration: 0 Minutes
While patents are a rich source of data, they are known for being vague and difficult to understand. Of course, this is by design. But how does vague-patenting-as-a-tactic impact the creation of a report like this, and what are some ways this can be tackled to ensure the analysis is accurate?
| Additional Resources |
|---|
| Access the Full Report Now |
Module 5
Breaking Down the Report
Duration: 0 Minutes
While the applications of CRISPR technology are seemingly endless, our team discusses how they approached the report and why certain areas were explored while others were omitted.
| Additional Resources |
|---|
| Access the Full Report Now |